|
 |
Orphenadrine CitrateThis page contains recent news articles, when available, and an overview of Orphenadrine Citrate but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Orphenadrine Citrate (when available) Orphenadrine is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. Orphenadrine is an anticholinergic with a predominantly central effect and only a weak peripheral effect. In addition, it has mild antihistaminic and local anaesthetic properties. Parkinson's syndrome is the consequence of a disturbed balance between cholinergic and dopaminergic neurotransmission in the basal ganglia caused by a decrease in dopamine. Orphenadrine restores the physiological equilibrium and has a favourable effect on the rigidity and tremor of Parkinson's disease and Parkinsonian syndromes. The effect is somewhat less on bradykinesia. Indicated for the treatment of Parkinson's disease. Mechanism Of Action: Orphenadrine binds to both histamine H1 receptors and NMDA receptors. It restores the motor disturbances induced by neuroleptics, in particular the hyperkinesia. The dopamine deficiency in the striatum increases the stimulating effects of the cholinergic system. This stimulation is counteracted by the anticholinergic effect of orphenadrine. It may have a relaxing effect on skeletal muscle spasms and it has a mood elevating effect. News Articles on Orphenadrine Four Pharmaceutical Companies Pay $124 Million for Submission of False Claims ... - Oct 19, 2009 ...flecainide acetate, selegiline HCL, Orphenadrine Citrate Aspirin and Caffeine tablets, Triamterene/Hydrochlorothiazide, Propoxyphene HCL, ... Reuters Protecting Competition, the Federal Trade Commission Approves … - Jul 20, 2005 Orphenadrine citrate ER, a muscle relaxant, has annual US generic sales of approximately ... Likewise, in the orphenadrine citrate ER and rifampin markets, ... i-newswire.com Akorn, Inc. Announces Product Approval for Orphenadrine Citrate … - May 24, 2006 BUFFALO GROVE, Ill. -- Akorn, Inc. (AMEX:AKN) today announced that it has received an ANDA approval for Orphenadrine Citrate Injection USP. ... Free with registration - Business Wire - AccessMyLibrary.com … Code - 77 Ill. Adm. Code 790.6820 ORPHENADRINE CITRATE ( … - Aug 10, 2005 77 Ill. Adm. Code 790.6820 ORPHENADRINE CITRATE (Repealed) Repealed. (Source: Repealed at 17 Ill. Reg. 15916, effective September 20, 1993) ... Pay-Per-View - Illinois Administrative Code - Loislaw Novartis' purchase of Eon approved with conditions. - Aug 29, 2005 In the orphenadrine citrate ER and rifampin markets Impax Laboratories Inc. and VersaPharm, respectively, are the only other generic competitors. ... $9.94 - Chain Drug Review - Alacra Store BRIEFS - Jul 20, 2005 ...hydrochloride tablets, orphenadrine citrate extended release tablets and rifampin oral capsules in the United States to Amide Pharmaceutical Inc. ... Pay-Per-View - Newsday - ProQuest Archiver Community airs concerns , Laurelton residents squre off with a local... - Mar 3, 2005 Eon makes orphenadrine citrate, an active ingredient found in a generic version ... Increased production of orphenadrine citrate could raise the amount of ... Pay-Per-View - Newsday - ProQuest Archiver Article: Novartis' purchase of Eon approved with conditions.(Novartis... - Aug 29, 2005 Furthermore, Novartis, through its Sandoz generic pharmaceutical unit, will supply Amide with orphenadrine citrate ER and desipramine HCI tablets until ... Pay-Per-View - Chain Drug Review - HighBeam Research Federal Register 2005 - 70 FR 42548 Novartis AG; Analysis of Agreement... - Jul 25, 2005 ...and the Sandoz assets necessary to manufacture and market orphenadrine citrate ER tablets and rifampin oral capsules in the United States. ... Pay-Per-View - Federal Register 2005 - Loislaw FDA finds Sandoz paperwork troubling - Aug 27, 2008 The plant, which employs about 450, makes generic medicines, including the heart drug metoprolol succinate, muscle relaxer orphenadrine citrate and ... News & Observer ALSO NOTED: Aphton files for bankruptcy; Akorn wins FDA OK; and much … - May 23, 2006 Akorn shares were on the rise after reporting FDA approval of an ANDA for Orphenadrine Citrate Injection. Report. > Wyeth has developed a new contraceptive ... FierceBiotech Article: Amide gets 3 products in Novartis divestiture - The Record (... - Jul 20, 2005 ...desipramine hydrochloride, a tricyclic antidepressant; orphenadrine citrate ER, a muscle relaxant; and rifampin; a drug used in treating tuberculosis. ... Pay-Per-View - The Record - HighBeam Research Akorn gets approval for injection drug - May 25, 2006 The company will make the Orphenadrine Citrate injection in its Decatur facility. The launch is expected in the third quarter. ... $2.95 - Daily Herald - NewsBank Local Focus.(Business) | Article from Daily Herald (Arlington... - May 25, 2006 The company will make the Orphenadrine Citrate injection in its Decatur facility. The launch is expected in the third quarter. ... Pay-Per-View - Daily Herald - HighBeam Research Drug/Medical Device - Mar 14, 2006 Norflex BID/Norflex Injectable (Orphenadrine Citrate), Musculoskeletal Pain, Dryness Of Mouth, Tachycardia, Palpitations, Urine Retention, Blurred Vision, ... $70.00 - Revere Reports - Revere United States top 200 generic drugs by retail sales in dollars and... - Mar 6, 2006 ...-16.1 177 Nadolol 36906 -8.1 178 Atenolol Chlorthal 36749 0.1 179 Methimazole 36587 -2.3 180 Ciclopirox 36259 576.6 181 Orphenadrine Citrate 36149 -9.4 ... $20.00 - Drug Topics - Alacra Store Novartis Receives US Regulatory Approval for Completion of Eon Labs … - Jul 19, 2005 Pursuant to the Consent Decree, Novartis will divest three generic pharmaceutical products, Desipramine HCl, Orphenadrine Citrate ER and Rifampin, ... primezone.com United States top 200 generic drugs by retail sales in dollars for... - Feb 28, 2005 152 Butorphanol NS 40319 153 Nadolol 40174 154 Orphenadrine citrate 39883 155 Meclizine HCl 39616 156 Dextroamphetamine Sf 39561 157 Butalbital compound ... $20.00 - Chain Drug Review - Alacra Store New Jersey Administrative Code - 10:58A-4.3 HCPCS procedure codes … - Aug 16, 2005 0.5 mg 152.00 J2352 Injection, octreotide acetate, 1 mg 152.87 J2355 Injection, oprelvekin, 5 mg 258.75 J2360 Injection, orphenadrine citrate, (Norflex, ... Pay-Per-View - New Jersey Administrative Code - Loislaw Novartis completes Eon Labs acquisition.(Brief Article) - Aug 1, 2005 These are desipramine, orphenadrine citrate and rifampin, which had aggregate sales of around $5.0 million in 2004. They have been sold to Amide ... $4.95 - Pharma Marketletter - ECNext Brand Names/Synonyms: Orphenadrine Citrate is also known by the following brand names and/or synonymsAntiflex; BS-5930; Banflex; Biorphen; Brocadisipal; Brocasipal; Disipal; Flexoject; Mephenamine; Mio-Rel; Myolin; Myotrol; Norflex; O-Methyldiphenhydramine; Orfro; Orphenadine; Orphenadrin; Orphenadrine; Orphenadrine Citrate; Orphenate; Orphenedrine; WS 2434 Drug Category: Orphenadrine Citrate is categorized under the following by the FDA: Muscle Relaxants; Antiparkinson Agents; Antidyskinetics; Skeletal Muscle Relaxants; ATC:M03BC01; ATC:N04AB02 Dosage Forms: TABLET (EXTENDED-RELEASE) Absorption: Orphenadrine is almost completely absorbed in the gastrointestinal tract. Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: N,N-dimethyl-2-[(2-methylphenyl)-phenyl-methoxy]-ethanamine |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
